CTS’s third quarter was marked by robust growth in diversified end markets and execution on margin expansion initiatives, resulting in a positive market reaction. Management attributed the improved quality of earnings to rising demand in medical and industrial segments, as well as effective cost discipline. CEO Pratik Trivedi highlighted that “strong execution drove record profitability and robust cash generation,” citing a 42.2% gross margin and notable expansion in the company’s end-market mix. The company’s focus on operational performance and a favorable product mix contributed significantly to these results.
Is now the time to buy CTS? Find out in our full research report (it’s free for active Edge members).
CTS (CTS) Q3 2026 highlights:
- Revenue $149.6 million vs S&P analysts’ estimates of $145.9 million (4.6% year-on-year growth, 2.5% beat)
- Adjusted EPS $0.77 vs S&P analysts’ estimates of $0.65 (17.9% beat)
- Adjusted EBITDA $37 million vs analyst estimates of $33.41 million (24.7% margin, 10.7% beat)
- Revenue guidance The company lifted its revenue guidance for the full year to $585 million at the midpoint from $575 million, a 1.7% increase
- Adjusted EPS guidance Management raised its full-year adjusted EPS guidance to $2.83 at the midpoint, a 7.8% increase
- Operating margin 17.4%, up from 14.8% in the same quarter last year
- Market capitalization $1.78 billion
While we enjoy listening to the management’s commentary, our favorite part of earnings calls is the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.
Our top 5 analyst questions from CTS’s Q3 earnings call
-
Gary Prestopino (Barrington): asked if the Millar acquisition would be accretive to EBITDA margins. CFO Ashish Agrawal replied that while gross margin will be accretive, EBITDA margin accretion will take time as synergies are realized.
-
Jaeson Schmidt (Lake Street): questioned Millar’s customer concentration risk. Agrawal clarified that Millar’s concentration will not materially impact CTS’s overall customer risk profile.
-
Jaeson Schmidt (Lake Street): inquired about the drivers behind transportation segment growth. CEO Pratik Trivedi explained that growth was modest and primarily from the commercial vehicle segment, with automotive markets still flat.
-
John Franzreb (Sidoti & Co.): asked about the financing of the Millar acquisition. Agrawal confirmed it was funded entirely with cash, not borrowings.
-
Hendi Susanto (Gabelli Funds): sought clarity on the sustainability of high gross margins. Agrawal noted that margins benefited from a favorable mix this quarter but may normalize in coming quarters, though long-term expansion remains a goal.
Catalysts in upcoming quarters
In the coming quarters, the StockStory team will be closely monitoring (1) the pace and success of Millar’s integration and its impact on CTS’s product portfolio, (2) the sustainability of margin improvements as end-market mix evolves, and (3) the company’s ability to maintain growth in industrial and medical segments despite transportation market headwinds. Execution on new product launches and customer wins will also be key indicators of ongoing momentum.
CTS currently trades at $62.40, up from $53.92 just before the earnings. At this price, is it a buy or sell? The answer lies in our full research report (it’s free).
Our favorite stocks right now
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.
